Mode
Text Size
Log in / Sign up
N/A N=244 Randomized Health Services Research

Sexual Health Texting Intervention to Support Adolescent Females

Teen Sexual Health

Enrolled (actual)
244
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: Dual Protection Behaviors, Reported in Surveys and Reviewed in the Medical Record. — 7; 6; 8; 8 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
text message intervention (Behavioral)
Age
Pediatric, Adult · 13+ yrs
Sex
Female
Sponsor
Denver Health and Hospital Authority
Primary completion
Jan 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Dual Protection Behaviors, Reported in Surveys and Reviewed in the Medical Record.
7; 6; 8; 8; 7; 11
SECONDARY
Use of the Most Effective Contraception Methods: Long Acting Reversible Contraceptives (LARCs)
18; 16; 18; 18; 17; 17
SECONDARY
Knowledge, Motivation, and Attitudes Toward Contraception, Condom Use and Dual Protection in Surveys
10.46; 10.90; 11.59; 13.57; 11.97; 13.64
SECONDARY
Unprotected Vaginal Sex at Baseline, 3 and 6 Months Post-baseline (Formerly Incidence of Unintended Pregnancy and STIs)
23; 26; 18; 20; 17; 21

Summary

This study aims to use a text messaging intervention to prevent unintended teen pregnancy and transmission of sexually transmitted disease. The study will be informed by a formative qualitative phase (February 2014 - January 2015) which will include individual qualitative interviews and focus groups with teens to elucidate and explore the barriers to effective contraceptive use and sexually transmitted disease (STD) prevention and to obtain feedback on the developed intervention. The second efficacy phase will randomize subjects to the texting intervention or to usual care.

Eligibility Criteria

Inclusion Criteria

  • biologically female;
  • between 13 and 18 years of age;
  • not currently pregnant or trying to become pregnant;
  • have texting capability; and
  • able to read/write/speak in English.

Exclusion Criteria

  • not meeting inclusion criteria outlined above
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02419690). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search